The chemokine receptor CCR7 directs DC trafficking to LNs27 and we observed increased CCR7 expression on all three tumor-resident MHC-II+CD11c+ DC populations after m1928z-CD40L CAR T cell treatment: CD11b−CD103− DNs, CD11b−CD103+ cDC1s, and CD11b+CD103− cDC2s (Fig. 1e). This evidence concerns the gene CCR7 and neoplasm.